Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Enrolling by invitation Not applicable Interventional

Train and EMPOWER A Community Health Workforce

ClinicalTrials.gov ID: NCT06868498

Public ClinicalTrials.gov record NCT06868498. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 6, 2026, 3:23 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The investigators propose a multi-step approach to improve access to mental health care. The plan focuses on three goals: increasing diversity in the mental health workforce, bringing more expertise into the community, and strengthening the community's ability to address the factors that impact mental health. To do this, the TEACH study team will work with students from underrepresented groups at a minority-serving institution (MSI). Students will be provided the opportunity to obtain their CHW Certification while receiving course credit for their degree. Students will then be eligible to participate in an internship to utilize their skills. The TEACH study team will help these students with their training, supervision, and ongoing support. These students will then be able to work with their communities to tackle common mental health issues and the social factors that contribute to those problems.

Study identification

NCT ID
NCT06868498
Recruitment status
Enrolling by invitation
Study type
Interventional
Phase
Not applicable
Lead sponsor
Baylor Research Institute
Other
Enrollment
250 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 5, 2024
Primary completion
May 30, 2028
Completion
Nov 30, 2029
Last update posted
Aug 10, 2026

2024 – 2029

United States locations

U.S. sites
2
U.S. states
1
U.S. cities
2
Facility City State ZIP Site status
The University of Texas at Arlington Arlington Texas 76019
Baylor Scott and White Research Institute Dallas Texas 75204

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06868498, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 10, 2026 · Synced Sep 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06868498 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →